News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2025 Caitlin E. Cox December 01, 2025
News Daily News Frail Patients Stand to Gain Most From Cardiac Rehab Michael O'Riordan November 26, 2025
News Daily News Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE Michael O'Riordan November 24, 2025
News Daily News Risk Calculators Miss Many Patients Who Present With First MI Michael O'Riordan November 21, 2025
News Daily News High Adolescent BP Tied to Subclinical Disease in Middle Age Michael O'Riordan November 20, 2025
News Daily News Chronic Pain Linked to Increased Risk for Incident Hypertension L.A. McKeown November 20, 2025
News Daily News Online Calculator Allows Young Adults to See How Their 30-Year CV Risk Compares to Peers’ Yael L. Maxwell November 19, 2025
News Conference News AHA 2025 Olezarsen Cuts Triglycerides, Pancreatitis Risk in Severe Hypertriglyceridemia Michael O'Riordan November 14, 2025
Presentation Cardiovascular Interventions 2025 Cardiology’s Evidence Crisis and What We Can Do About It Presenter: Robert W. Yeh November 14, 2025
News Daily News Déjà Vu All Over Again? Results of Intracoronary Stem Cell Study Questioned Yael L. Maxwell November 13, 2025
Presentation Cardiovascular Interventions 2025 New Guidelines for IVUS: Finally, the Indication is 1A Presenter: Evan Shlofmitz November 12, 2025
News Conference News AHA 2025 Oral PCSK9 Inhibitor Enlicitide Cuts LDL Cholesterol: CORALreef Lipids Michael O'Riordan November 10, 2025
News Daily News Fish Oil Halves CV Risk in Patients on Dialysis: PISCES Yael L. Maxwell November 10, 2025
News Conference News AHA 2025 DECAF: Daily Coffee, Not Abstinence, Beneficial for AF Patients Michael O'Riordan November 09, 2025
News Conference News AHA 2025 Stopping DOACs After Successful AF Ablation Feasible in Low-risk Patients: OCEAN Michael O'Riordan November 08, 2025
News Conference News AHA 2025 Triple Agonist Appears Promising for Patients With Severe Hypertriglyceridemia Caitlin E. Cox November 08, 2025
News Conference News AHA 2025 Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV Michael O'Riordan November 08, 2025
News Conference News AHA 2025 CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia Todd Neale November 08, 2025